Published in Healthcare Finance, Tax and Law Weekly, July 11th, 2007
Under the terms of Novator's revised offer, Actavis shareholders would receive EUR1.075 per share. This represents a premium of 19.6% to Actavis's share price on 9 May 2007, the day immediately prior to Novator's announcement of its initial offer, which was subsequently published on 1 June 2007. The revised offer represents an additional10.6% increase on the initial offer of EUR 0.98 per share.
Additional cash payment clause
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.